We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+28.05%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$10.3B
AUM Growth
+$5.25B
Cap. Flow
+$4.62B
Cap. Flow %
45%
Top 10 Hldgs %
41.75%
Holding
2,600
New
918
Increased
493
Reduced
472
Closed
701

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$353M
2
MSFT icon
Microsoft
MSFT
+$352M
3
AAPL icon
Apple
AAPL
+$256M
4
BABA icon
Alibaba
BABA
+$189M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$125M

Sector Composition

Rank Sector Weight
1 Technology 14.28%
2 Consumer Discretionary 10.77%
3 Healthcare 5.09%
4 Industrials 4.03%
5 Financials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RETA
1051
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$698K 0.01%
+5,644
New +$742K
WPG
1052
DELISTED
Washington Prime Group Inc.
WPG
$697K 0.01%
+107,023
New +$753K
NVO
1053
Novo Nordisk
NVO
$207B
$694K 0.01%
+19,884
New +$687K
FSR
1054
DELISTED
Fisker Inc.
FSR
$694K 0.01%
+47,391
New +$697K
TWNK
1055
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$693K 0.01%
47,338
+14,144
+43% +$190K
VRAY
1056
CALL
DELISTED
ViewRay, Inc.
VRAY
$693K 0.01%
181,300
+81,300
+81% +$288K
BUD icon
1057
AB InBev
BUD
$156B
$691K 0.01%
9,890
-1,372
-12% -$86.8K
NVEE
1058
DELISTED
NV5 Global
NVEE
$691K 0.01%
35,064
-19,776
-36% -$333K
AMKR icon
1059
Amkor Technology
AMKR
$11.9B
$687K 0.01%
45,548
+7,407
+19% +$101K
LBTYA icon
1060
Liberty Global Class A
LBTYA
$3.66B
$687K 0.01%
28,357
+20,806
+276% +$463K
FTCH
1061
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$687K 0.01%
10,759
-16,573
-61% -$733K
SJR
1062
DELISTED
Shaw Communications Inc.
SJR
$686K 0.01%
+39,086
New +$689K
MATX icon
1063
Matsons
MATX
$6.66B
$684K 0.01%
+12,014
New +$656K
DBD
1064
DELISTED
Diebold Nixdorf Incorporated
DBD
$684K 0.01%
64,131
+47,923
+296% +$435K
CXP
1065
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$683K 0.01%
47,611
+7,535
+19% +$95.9K
PACW
1066
DELISTED
PacWest Bancorp
PACW
$681K 0.01%
26,823
-30,730
-53% -$686K
FORR icon
1067
Forrester Research
FORR
$228M
$677K 0.01%
+16,157
New +$646K
TTGT icon
1068
TechTarget
TTGT
$276M
$677K 0.01%
+11,453
New +$592K
FSM icon
1069
Fortuna Silver Mines
FSM
$3.61B
$675K 0.01%
+81,902
New +$567K
OLLI icon
1070
Ollie's Bargain Outlet
OLLI
$4.62B
$675K 0.01%
+8,260
New +$722K
CACC icon
1071
Credit Acceptance
CACC
$6.26B
$672K 0.01%
1,942
-2,479
-56% -$810K
SCOAU
1072
DELISTED
ScION Tech Growth I Unit
SCOAU
$671K 0.01%
+65,000
New +$670K
NBIX icon
1073
Neurocrine Biosciences
NBIX
$15.6B
$669K 0.01%
6,983
-11,840
-63% -$1.14M
EOLS icon
1074
Evolus
EOLS
$580M
$668K 0.01%
198,940
+160,198
+413% +$601K
GRWG icon
1075
GrowGeneration
GRWG
$102M
$667K 0.01%
+16,575
New +$446K

Similar funds

Michael Gelband's Q4 2020 Portfolio in Review

As of Q4 2020, Michael Gelband held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Michael Gelband deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.

  • Michael Gelband's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
  • Michael Gelband added most to Amazon in Q4 2020, an estimated $353M increase.
  • Michael Gelband's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
  • Michael Gelband fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
  • Michael Gelband's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
  • Michael Gelband opened 918 new positions and closed 701 in Q4 2020.
  • Michael Gelband's portfolio value rose 105% quarter-over-quarter to $10.3B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.